| International consensus diagnostic criteria for neuromyelitis optica spectrum disorders DM Wingerchuk, B Banwell, JL Bennett, P Cabre, W Carroll, T Chitnis, ... Neurology 85 (2), 177-189, 2015 | 3834 | 2015 |
| MOG encephalomyelitis: international recommendations on diagnosis and antibody testing S Jarius, F Paul, O Aktas, N Asgari, RC Dale, J De Seze, D Franciotta, ... Journal of neuroinflammation 15 (1), 1-10, 2018 | 668 | 2018 |
| Eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder SJ Pittock, A Berthele, K Fujihara, HJ Kim, M Levy, J Palace, I Nakashima, ... New England Journal of Medicine 381 (7), 614-625, 2019 | 588 | 2019 |
| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 570 | 2015 |
| The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features MA Nagel, RJ Cohrs, R Mahalingam, MC Wellish, B Forghani, A Schiller, ... Neurology 70 (11), 853-860, 2008 | 563 | 2008 |
| Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis SB Syc, S Saidha, SD Newsome, JN Ratchford, M Levy, ET Ford, ... Brain 135 (2), 521-533, 2012 | 385 | 2012 |
| Treatment of neuromyelitis optica: review and recommendations DJ Kimbrough, K Fujihara, A Jacob, MA Lana-Peixoto, MI Leite, M Levy, ... Multiple sclerosis and related disorders 1 (4), 180-187, 2012 | 339 | 2012 |
| Epidemiology of neuromyelitis optica in the United States: a multicenter analysis MA Mealy, DM Wingerchuk, BM Greenberg, M Levy Archives of neurology 69 (9), 1176-1180, 2012 | 330 | 2012 |
| Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy MA Mealy, DM Wingerchuk, J Palace, BM Greenberg, M Levy JAMA neurology 71 (3), 324-330, 2014 | 317 | 2014 |
| Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography JL Bennett, J de Seze, M Lana-Peixoto, J Palace, A Waldman, ... Multiple Sclerosis Journal 21 (6), 678-688, 2015 | 279 | 2015 |
| Neuromyelitis optica S Jarius, F Paul, BG Weinshenker, M Levy, HJ Kim, B Wildemann Nature Reviews Disease Primers 6 (1), 85, 2020 | 234 | 2020 |
| Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange H Abboud, A Petrak, M Mealy, S Sasidharan, L Siddique, M Levy Multiple Sclerosis Journal 22 (2), 185-192, 2016 | 229 | 2016 |
| The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity EJ Weeber, M Levy, MJ Sampson, K Anflous, DL Armstrong, SE Brown, ... Journal of Biological Chemistry 277 (21), 18891-18897, 2002 | 216 | 2002 |
| Superficial siderosis: a case report and review of the literature M Levy, C Turtzo, RH Llinas Nature clinical practice Neurology 3 (1), 54-58, 2007 | 204 | 2007 |
| MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder R Narayan, A Simpson, K Fritsche, S Salama, S Pardo, M Mealy, F Paul, ... Multiple sclerosis and related disorders 25, 66-72, 2018 | 202 | 2018 |
| The COVID-19 pandemic and the use of MS disease-modifying therapies G Giovannoni, C Hawkes, J Lechner-Scott, M Levy, E Waubant, J Gold Multiple sclerosis and related disorders 39, 2020 | 198 | 2020 |
| Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients L Kremer, M Mealy, A Jacob, I Nakashima, P Cabre, S Bigi, F Paul, ... Multiple Sclerosis Journal 20 (7), 843-847, 2014 | 194 | 2014 |
| Neuromyelitis optica pathogenesis and aquaporin 4 DJ Graber, M Levy, D Kerr, WF Wade Journal of neuroinflammation 5 (1), 1-21, 2008 | 191 | 2008 |
| Mitochondrial regulation of synaptic plasticity in the hippocampus M Levy, GC Faas, P Saggau, WJ Craigen, JD Sweatt Journal of Biological Chemistry 278 (20), 17727-17734, 2003 | 188 | 2003 |
| Treatment of neuromyelitis optica spectrum disorder: acute, preventive, and symptomatic RA Kessler, MA Mealy, M Levy Current treatment options in neurology 18, 1-15, 2016 | 149 | 2016 |
Maureen MealyJohns Hopkins University School of MedicineVerified email at jhmi.edu
